Trexquant Investment’s AMAG Pharmaceuticals AMAG Stock Holding History

Trexquant Investment’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-51,966	Closed	-$789K	–	1439
2018 Q4	$789K	Buy	51,966 +31,175	+150%	+$594K	0.05%	490
2018 Q3	$416K	Buy	+20,791	New	+$473K	0.03%	602
2018 Q1	–	Sell	-28,940	Closed	-$383K	–	1501
2017 Q4	$383K	Buy	28,940 +6,618	+30%	+$99.8K	0.04%	627
2017 Q3	$412K	Buy	+22,322	New	+$416K	0.1%	342
2016 Q2	–	Sell	-18,000	Closed	-$421K	–	1208
2016 Q1	$421K	Sell	18,000 -825	-4%	-$19.6K	0.05%	615
2015 Q4	$568K	Sell	18,825 -18,075	-49%	-$584K	0.05%	633
2015 Q3	$1.47M	Buy	36,900 +25,700	+229%	+$1.6M	0.13%	264
2015 Q2	$773K	Sell	11,200 -8,100	-42%	-$510K	0.09%	441
2015 Q1	$1.05M	Buy	19,300 +11,456	+146%	+$546K	0.11%	338
2014 Q4	$334K	Buy	+7,844	New	+$283K	0.06%	650

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Trexquant Investment's AMAG Position: Q1 2019 in Review

Trexquant Investment sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 51,966 shares — an estimated $789K sold.

Trexquant Investment first reported a position in AMAG in Q4 2014 and held it in 10 quarters. The position peaked at $1.47M in Q3 2015. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.

Trexquant Investment reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
Trexquant Investment sold 51,966 AMAG Pharmaceuticals shares in Q1 2019, an estimated $789K.
Trexquant Investment first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 10 quarters.
Trexquant Investment's AMAG Pharmaceuticals position peaked at $1.47M in Q3 2015.
166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.